NasdaqGS:AMGN
NasdaqGS:AMGNBiotechs

Is There Still Value in Amgen After Its Strong 2025 Share Price Run?

Wondering if Amgen’s share price already reflects the upside, or if there is still value on the table? You are not alone, and this article is going to tackle that head on from an investor’s perspective. Amgen’s stock has quietly put in a solid run, with the price up 1.9% over the last week and 27.8% year to date, even after a small 1.8% pullback over the last month that reminds us risk perceptions can change quickly. Recent attention has centered on Amgen’s expanding pipeline in areas like...
NYSE:ITW
NYSE:ITWMachinery

Illinois Tool Works (ITW): Is the Quiet Grind Higher Backed by Its Current Valuation?

Illinois Tool Works (ITW) has been quietly grinding higher this month, and that slow climb is catching investors attention. With steady earnings growth and a long dividend track record, the stock invites a closer look. See our latest analysis for Illinois Tool Works. At around $251.57 per share, Illinois Tool Works is treading water in the short term, with a modestly positive year to date share price return but a much stronger three year total shareholder return suggesting the longer term...
NasdaqGS:WMT
NasdaqGS:WMTConsumer Retailing

The Bull Case For Walmart (WMT) Could Change Following FDA Formula Warning And ESOP Shift - Learn Why

In recent weeks, Walmart has expanded and refreshed key product lines through partners like No Cap! Soda Pop, AXIL Brands, and Dove x Crumbl, while also facing an FDA warning letter over recalled ByHeart infant formula remaining on its shelves after a nationwide recall. At the same time, Walmart has closed older employee stock ownership plan shelf registrations, filed a new multi-billion-dollar ESOP-related registration, and joined the Nasdaq Composite Index, underscoring how employee...
NYSE:HPE
NYSE:HPETech

Hewlett Packard Enterprise (HPE): Assessing Valuation After a Strong Multi‑Year Shareholder Return Run

Hewlett Packard Enterprise (HPE) has quietly rewarded patient shareholders, with the stock climbing about 20% over the past month and 16% over the past year, far outpacing many legacy tech peers. See our latest analysis for Hewlett Packard Enterprise. The latest move has been driven less by headline grabbing announcements and more by investors warming to HPE’s improving growth profile and cash generation. The current 1 year total shareholder return of 16.25% sits on top of a powerful 5 year...
NasdaqGS:STX
NasdaqGS:STXTech

Should Nasdaq-100 Entry and Dividend Hike Require Action From Seagate Technology (STX) Investors?

Seagate Technology Holdings has now joined the Nasdaq-100 index and modestly lifted its quarterly dividend to US$0.74 per share, underscoring confidence in its AI-driven, high-capacity storage portfolio and Mozaic HAMR products. This combination of index inclusion, AI-linked demand momentum, and dividend growth highlights how core infrastructure suppliers are increasingly central to the data economy story. We’ll now examine how Nasdaq-100 inclusion, with its potential to broaden Seagate’s...
NasdaqGS:BIIB
NasdaqGS:BIIBBiotechs

Biogen (BIIB): Reassessing Valuation After New QALSODY Data, Pipeline Progress and Renewed Growth Optimism

Biogen (BIIB) just got a fresh catalyst, with new long term Phase 3 and extension data for QALSODY in SOD1 ALS indicating slower disease decline when treatment starts earlier, and some patients even regaining lost function. See our latest analysis for Biogen. That QALSODY data lands in the middle of a real sentiment reset for Biogen, with the share price at $174.7 and a roughly 25 percent 90 day share price return signalling fresh momentum despite a weak three year total shareholder...
NasdaqCM:INVZ
NasdaqCM:INVZElectronic

Innoviz Technologies (NasdaqCM:INVZ): Revisiting Valuation After New LiDAR and NVIDIA Edge AI Showcase Plans

Innoviz Technologies (NasdaqCM:INVZ) is back on investors radar after announcing it will showcase its latest LiDAR lineup, including InnovizThree and updated InnovizTwo and InnovizSMART platforms, at CES 2026 in Las Vegas. See our latest analysis for Innoviz Technologies. Even with the CES showcase and expanding LiDAR lineup, sentiment has been shaky, with a sharp 90 day share price return of around negative 45 percent and a five year total shareholder return loss above 90 percent. This...
NYSE:JPM
NYSE:JPMBanks

Has JPMorgan Run Too Far After Its 2024 Surge and Strong Excess Returns Outlook?

If you are wondering whether JPMorgan Chase is still worth buying after such a strong run, you are not alone. This is exactly the question we will unpack here. The stock has climbed 1.0% over the last week, 8.4% in the past month, and is now up 34.6% year to date, building on hefty gains of 38.4% over 1 year, 165.0% over 3 years, and 193.5% over 5 years. Behind those moves, investors have been reacting to a mix of macro headlines, from shifting interest rate expectations to ongoing...
NYSE:MKL
NYSE:MKLInsurance

Has Markel Group’s Recent 27% Rally Already Priced In Future Growth?

Wondering if Markel Group at around $2,180 a share is still a smart buy or if the easy money has already been made? Let us unpack what the current price is really baking in. The stock has climbed 1.0% over the last week, 7.3% over the past month, and is up 27.1% year to date, with a strong 25.7% gain over the last year and a hefty 120.1% over five years. This naturally raises questions about how much upside is left. Recent headlines have highlighted Markel Group’s ongoing evolution as a...